Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

    This grant funds research on causes, biological mechanisms, and early detection of non-hereditary early-onset cancers (ages 18-49) to inform prevention and control strategies.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant was recently updated

    This grant has transitioned from forecasted to posted and is now accepting applications.

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.

    HHS-NIH11Due Nov 10, 2026$150,000

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

    Explore existing data to uncover cancer risk insights, seeking to understand outcomes like survival and treatment response.

    HHS-NIH11Due Nov 5, 2026· 19d$1,750,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted

    Forecast to Publish a Funding Opportunity Announcement for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

    The National Cancer Institute will fund hypothesis-driven research in cancer epidemiology cohort studies to address gaps in cancer causes and survivorship, supporting cohort maintenance and data sharing.

    HHS-NIH11Due Jul 5, 2029

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted